±è¼º±Ô(68³âÁ¹) ¸í¿¹ ±³¼ö´Ô ¸ðÄ£»ó
Àå»óÈ£(81Á¹, ¿¬¼¼³»°ú) ¼±»ý´Ô ¸ðÄ£»ó
2015³â ¼¼È£È¸ Á¤±â °¡À» »êÇà ¾È³»
ÀÌÀåÈÆ(¿¬¼¼81Á¹, ÀÌÀåÈÆ³»°ú) µ¿¹® ºùºÎ»ó
Á¤ÀçÈ£(¿¬¼¼97³âÁ¹, ±¹Á¦¼º¸ðº´¿ø)µ¿¹® ¸ð..
°³²¼¼ºê¶õ½ºº´¿ø ¾Èö¹Î±³¼ö´Ô Â÷³² °áÈ¥..
¼ÕÈñ¿µ (¿¬¼¼ 75³âÁ¹)µ¿¹®ºÎÄ£»ó
±è¼¼±Ô ±³¼ö´Ô(¼¼ºê¶õ½ºº´¿ø) ºÎÄ£»ó
240718 Case conference : SAT and SB..
2023.10.31 journal club
Chest conference Oncogene fusion-po..
Oncogene fusion-positive lung adeno.. 
BLESS study 2013 JAMA
BAT study JAMA 2013
EMBRACE study 2013 lancet
macrolide resistance lancet rev..
macrolide cardiac risk AJRCCM 2..
ANCA associated ILD review2 